HomeExit StrategyHough Ear Institute Licenses Hearing Loss Treatment

Hough Ear Institute Licenses Hearing Loss Treatment

Hough Ear Institute licensed a novel hearing-loss treatment, which a local team of Hough scientists developed, to Boehringer Ingelheim, an international pharmaceutical firm.

The drug was codeveloped by OKC-based Autigen, a subsidiary of Otologic. Dr. Elaine Hamm is president of both.

“Our drug works to combat hearing loss caused by a loss of cells in the cochlea called ‘inner hair cells.’” Hamm said. “Previously, once you lost those, they wouldn’t grow back. Our drug causes them to grow back.”

Boehringer Ingelheim intends to take the drug through the testing process with the aim of bringing it to market. In preclinical models, the scientific team led by Drs. Xiaoping Du, Matthew West and Richard Kopke has regenerated these sensory hair cells.

Sign up for our weekly newsletter for our weekly newsletter and get the latest 405 news & events happening straight to your inbox!

Featured Stories

2023 Innovator Awards

New ideas, new products and new ways to approach problems are what alter, advance and propel companies forward. In fact, 50% of the annual...

The Rise of Paycom

Paycom — one of Oklahoma’s fastest-growing and largest companies — busted through the billion-dollar revenue mark in 2021 and has seen double-digit revenue growth...

Force of Nature

The Asian-owned business community accounts for more than $1 billion in annual sales and about a quarter billion in payroll in Oklahoma. Now, the...